Stereotactic Focused Radiotherapy for Low-risk Prostate Cancer: Results of a Phase-II Trial
Paul Nguyen, Bertrand Donneaux, Céline Louis, Szusa Bodgal, Sven Philippi, Bérangère Frédérick, Sylvie Biver, Ludovic Harzé, Yves Lasar, Guillaume Vogin, Philippe Nickers | PO-1458 | ESTRO | 2023
Stereotactic APBI for Early-stage Breast Cancer: 3-year Outcomes of a Prospective Registry
Jonathan Cantalino, Monica Pernia Marin, David D’Ambrosio, Arica Hirsch, Malika Danner, Sonali Rudra, Simeng Suy, Sean Collins, Dawn Matsanka, Michael Good, Jing Feng, John Lamond, Deborah Markiewicz, Rachelle Lanciano, Olusola Obayomi-Davies, Brian Collins | PO-1249 | ESTRO | 2023
Stereotactic Reirradiation for Locally Recurrent Prostate Cancer after Definitive Radiotherapy
Giulio Francolini et al | PD-0576 | ESTRO | 2023
Dosimetric and Clinical Aspects of Lung SABR Delivered with Synchrony® Tracking on TomoTherapy
Marzia Cerrato et al | PD-0982 | ESTRO | 2023
Single-Fraction PSMA-PET- and Multiparametric MRI-Guided Focal SBRT for Prostate Cancer Local Recurrences
Felix Ehret et al | RSS | 2023
Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results
Christopher Mendez et al | RSS | 2023
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022
Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas – A randomized clinical trial
Marcin Miszczyk, Aleksandra Napieralska, Grzegorz Woźniak, Małgorzata Kraszkiewicz, Michał Gola, Michał Kalemba, Grzegorz Głowacki, Bartłomiej Tomasik, Magdalena Kocot-Kępska, Leszek Miszczyk | Radiother Oncol | 2022
2486: Correlation between Obesity and Treatment Failure Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer
D. Conroy, T. Sholklapper, M. K. K. Lawlor, J. M. Cantalino, A. Zwart, M. J. Ayoob, M. Danner, T. Yung, B. T. Collins, S. Lei, A. Rashid, D. Kumar, S. Suy, N. Aghdam, and S. P. Collins | ASTRO | 2022
194: Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial
K. P. Lui, K. Wang, R. C. Chen, B. L. Kane, C. A. Medbery III, K. Underhill Jr, J. R. Gray, A. V. Peddada, and D. B. Fuller | ASTRO | 2022
2026: Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy
P.S. Sridhar, P. Anuradha, C. Fareena Taj, S. Suresh, K. Roopesh, R. Ghosh, S. Bj, | ASTRO | 2022
2031: Evaluation of Early Cosmetic Outcome and Toxicity after 5-Fraction Stereotactic Partial Breast Irradiation in Early-Stage Breast Cancer: A Prospective Cohort Study
H.K. Byun, J.S. Chang, H.J. Kim, J. Kim, M.C. Han, S.Y. KIM, R.H. PARK, C.J. Kim, and Y.B. Kim | ASTRO | 2022
3195: Real-World Dose Delivery Accuracy of Prostate SBRT with Tomotherapy Based Target Tracking
L. Goddard, J. Tang, M. K. Garg, W. R. Bodner III, P. Brodin, K. Jeong, and W. A. Tome | ASTRO | 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
Jean-Philippe Pignol, Nienke Hoekstra, Derek Wilke, Hannah Dahn, Maureen Nolan, Frank Vicini | Front Oncol | 2021
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage
Bae SH, Cho KH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lee MH, Lim S, Jung JH, and Lim SH | Transl Cancer Res | 2022
Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma
Chen YX, Zhuang Y, Yang P, Fan J, Zhou J, Hu Y, Zhu WC, Sun J, Zeng ZC. | Technol Cancer Res Treat | 2020
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage
Bae SH, Cho KH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lee MH, Lim S, Jung JH, and Lim SH | Transl Cancer Res | 2022
High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment
Parisi E, Romeo A, Sarnelli A, Ghigi G, Bellia SR, Neri E, Micheletti S, Dipalma B, Arpa D, Furini G, Burgio MA, Genestreti G, Gurioli C, Sanna S, Bovolato P, Rea F, Storme G, Scarpi E, Arienti C, Tesei A, Polico R | Cancer Radiother | 2017
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis
Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M, Simontacchi G, Viggiano D, Lanfranchi B, Gonfiotti A, Topulli J, Olmetto E, Maragna V, Ferrari K, Bonti V, Comin C, Balduzzi S, D’Amico R, Lohr F, Voltolini L, Livi L | Clin Lung Cancer | 2019